Dallas, TXCIK 21061811 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
19 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Ea Series Trust | 230.8K | $26.56M | 26.3% | +230.8K | New Position |
| 2 | X4 Pharmaceuticals Inc | 3.72M | $14.89M | 14.7% | +3.72M | New Position |
| 3 | Sionna Therapeutics Inc | 197.1K | $8.11M | 8.0% | +197.1K | New Position |
| 4 |
| Relay Therapeutics Inc |
| 901.5K |
| $7.63M |
| 7.5% |
| +901.5K |
| New Position |
| 5 | Compass Pathways PLC | 819.7K | $5.66M | 5.6% | +819.7K | New Position |
| 6 | Pharvaris N V | 198.8K | $5.52M | 5.5% | +198.8K | New Position |
| 7 | Septerna Inc | 194.5K | $5.42M | 5.4% | +194.5K | New Position |
| 8 | Oruka Therapeutics Inc | 118.5K | $3.59M | 3.6% | +118.5K | New Position |
| 9 | Inhibikase Therapeutics Inc | 1.75M | $3.59M | 3.5% | +1.75M | New Position |
| 10 | Allogene Therapeutics Inc | 2.55M | $3.49M | 3.5% | +2.55M | New Position |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio